Informacje dodatkowe
| Water Retention | Minimal |
|---|---|
| Hepatotoxicity | Low risk |
| Lab Test | Not specific, but monitoring of liver and kidney function may be required |
| Strength | 40 mg |
| Also known as | Isoptin, Calan, Verelan |
| Blood pressure | Lowers blood pressure |
| Trade name | Calan, Isoptin, Verelan |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Chemical name | Verapamil hydrochloride |
| Formula | C27H38N2O4В·HCl |
| Substance class | Calcium channel blocker |
| Main action | Reduces the entry of calcium into cardiac and smooth muscle cells, leading to vasodilation and decreased heart rate |
| Half-life | 2.8 to 7.4 hours |
| Dosage (medical) | 80-120 mg orally three times a day or 180-240 mg in extended-release forms once daily for hypertension or angina |
| Dosage (sports) | Not applicable, as it is not typically used for performance enhancement in sports |
| Effects | Lowering of blood pressure, reduced angina, control of certain types of arrhythmias |
| Side effects | Dizziness, headache, constipation, nausea, hypotension, bradycardia, and potential heart failure exacerbation |
| Use in sports | Not commonly used in sports |
| Manufacturer | Abbott Healthcare Pvt. Ltd. |
Opinie
Na razie nie ma opinii o produkcie.